Cargando…

Chronic Kidney Disease Transdifferentiates Veins into a Specialized Immune–Endocrine Organ with Increased MYCN-AP1 Signaling

Most patients with end-stage renal disease (ESRD) and advanced chronic kidney disease (CKD) choose hemodialysis as their treatment of choice. Thus, upper-extremity veins provide a functioning arteriovenous access to reduce dependence on central venous catheters. However, it is unknown whether CKD re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saaoud, Fatma, Martinez, Laisel, Lu, Yifan, Xu, Keman, Shao, Ying, Zhuo, Jia L, Gillespie, Avrum, Wang, Hong, Tabbara, Marwan, Salama, Alghidak, Yang, Xiaofeng, Vazquez-Padron, Roberto I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252601/ https://www.ncbi.nlm.nih.gov/pubmed/37296603 http://dx.doi.org/10.3390/cells12111482

Ejemplares similares

Vein morphometry in end-stage kidney disease: Teasing out the contribution of age, comorbidities, and vintage to chronic wall remodeling
por: Labissiere, Xochilt, et al.
Publicado: (2022)

Editorial: Debates in cardiovascular pharmacology and drug discovery: 2022
por: Xu, Keman, et al.
Publicado: (2023)

An atypical case of hemodialysis access stent migration
por: Duque, Juan C., et al.
Publicado: (2022)

Early hyperlipidemia triggers metabolomic reprogramming with increased SAH, increased acetyl-CoA-cholesterol synthesis, and decreased glycolysis
por: Xu, Keman, et al.
Publicado: (2023)

Echocardiographic changes after arteriovenous fistula creation in hemodialysis patients
por: Manzur-Pineda, Karen, et al.
Publicado: (2022)

Editorial: Insights in cardiovascular therapeutics 2022—cardiovascular innate immunity
por: Xu, Keman, et al.
Publicado: (2023)

Aorta- and liver-generated TMAO enhances trained immunity for increased inflammation via ER stress/mitochondrial ROS/glycolysis pathways
por: Saaoud, Fatma, et al.
Publicado: (2023)

Cigarette Smoke and Morphine Promote Treg Plasticity to Th17 via Enhancing Trained Immunity
por: Shao, Ying, et al.
Publicado: (2022)

Procaspase-1 patrolled to the nucleus of proatherogenic lipid LPC-activated human aortic endothelial cells induces ROS promoter CYP1B1 and strong inflammation
por: Lu, Yifan, et al.
Publicado: (2021)

MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4
por: Xue, Chengyuan, et al.
Publicado: (2016)

Aorta in Pathologies May Function as an Immune Organ by Upregulating Secretomes for Immune and Vascular Cell Activation, Differentiation and Trans-Differentiation—Early Secretomes may Serve as Drivers for Trained Immunity
por: Lu, Yifan, et al.
Publicado: (2022)

IL-35 promotes CD4(+)Foxp3(+) Tregs and inhibits atherosclerosis via maintaining CCR5-amplified Treg-suppressive mechanisms
por: Shao, Ying, et al.
Publicado: (2021)

Novel Knowledge-Based Transcriptomic Profiling of Lipid Lysophosphatidylinositol-Induced Endothelial Cell Activation
por: Xu, Keman, et al.
Publicado: (2021)

Editorial: Endothelial cells as innate immune cells
por: Lu, Yifan, et al.
Publicado: (2022)

A Multicenter Randomized Clinical Trial of Hemodialysis Access Blood Flow Surveillance Compared to Standard of Care: The Hemodialysis Access Surveillance Evaluation (HASE) Study
por: Salman, Loay, et al.
Publicado: (2020)

ROS systems are a new integrated network for sensing homeostasis and alarming stresses in organelle metabolic processes
por: Sun, Yu, et al.
Publicado: (2020)

Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism
por: Shao, Ying, et al.
Publicado: (2021)

MYCN and the epigenome
por: He, Stanley, et al.
Publicado: (2013)

Age-related changes in monocytes exacerbate neointimal hyperplasia after vascular injury
por: Martinez, Laisel, et al.
Publicado: (2015)

ER stress mediates Angiotensin II-augmented innate immunity memory and facilitates distinct susceptibilities of thoracic from abdominal aorta to aneurysm development
por: Lu, Yifan, et al.
Publicado: (2023)

Is transdifferentiation in trouble?
por: Wells, William A.
Publicado: (2002)

Erythroid-transdifferentiated myeloid cells promote portal vein tumor thrombus in hepatocellular carcinoma
por: Zhu, Wei-Hang, et al.
Publicado: (2023)

A Novel Subset of CD95(+) Pro-Inflammatory Macrophages Overcome miR155 Deficiency and May Serve as a Switch From Metabolically Healthy Obesity to Metabolically Unhealthy Obesity
por: Johnson, Candice, et al.
Publicado: (2021)

Hyperlipidemia May Synergize with Hypomethylation in Establishing Trained Immunity and Promoting Inflammation in NASH and NAFLD
por: Drummer, Charles I. V., et al.
Publicado: (2021)

MYCN is amplified during S phase, and c-myb is involved in controlling MYCN expression and amplification in MYCN-amplified neuroblastoma cell lines
por: Aygun, Nevim, et al.
Publicado: (2019)

Implementation of the plasma MYCN/NAGK ratio to detect MYCN amplification in patients with neuroblastoma
por: Su, Yan, et al.
Publicado: (2020)

MYCN upregulates the transsulfuration pathway to suppress the ferroptotic vulnerability in MYCN-amplified neuroblastoma
por: Floros, Konstantinos V., et al.
Publicado: (2022)

MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma
por: Agarwal, Saurabh, et al.
Publicado: (2018)

Therapeutic potential of targeting MYCN: A case series report of neuroblastoma with MYCN amplification
por: Huang, Can, et al.
Publicado: (2020)

A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma
por: Zhang, Hai-Feng, et al.
Publicado: (2023)

Correlation Between MYCN Gene Status and MYCN Protein Expression in Neuroblastoma: A Pilot Study To Propose the Use of MYCN Immunohistochemistry in Limited-Resource Areas
por: Santiago, Teresa, et al.
Publicado: (2019)

The MYCN Protein in Health and Disease
por: Ruiz-Pérez, María Victoria, et al.
Publicado: (2017)

MYCN Function in Neuroblastoma Development
por: Otte, Jörg, et al.
Publicado: (2021)

MYCN and Metabolic Reprogramming in Neuroblastoma
por: Bansal, Mohit, et al.
Publicado: (2022)

Metastasis in neuroblastoma: the MYCN question
por: Bhavsar, Swapnil Parashram
Publicado: (2023)

MYCN-targeting miRNAs are predominantly downregulated during MYCN-driven neuroblastoma tumor formation
por: Beckers, Anneleen, et al.
Publicado: (2014)

Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors
por: Vaughan, Lynsey, et al.
Publicado: (2016)

Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma
por: Agarwal, Saurabh, et al.
Publicado: (2018)

Elimination of MYCN-Amplified Neuroblastoma Cells by Telomerase-Targeted Oncolytic Virus via MYCN Suppression
por: Tanimoto, Terutaka, et al.
Publicado: (2020)

Caspase-11 promotes high-fat diet-induced NAFLD by increasing glycolysis, OXPHOS, and pyroptosis in macrophages
por: Drummer, Charles, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_aj6ucpabv3l0ku1hf2aq30na8a